HRP20110436T1 - Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i - Google Patents

Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i Download PDF

Info

Publication number
HRP20110436T1
HRP20110436T1 HR20110436T HRP20110436T HRP20110436T1 HR P20110436 T1 HRP20110436 T1 HR P20110436T1 HR 20110436 T HR20110436 T HR 20110436T HR P20110436 T HRP20110436 T HR P20110436T HR P20110436 T1 HRP20110436 T1 HR P20110436T1
Authority
HR
Croatia
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
hydrogen
Prior art date
Application number
HR20110436T
Other languages
English (en)
Croatian (hr)
Inventor
Thomas Backer Ryan
Joseph Fisher Matthew
Lee Kuklish Steven
Patrick Hollinshead Sean
C.R. Smith Edward
Takeuchi Kumiko
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20110436T1 publication Critical patent/HRP20110436T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20110436T 2006-06-08 2011-06-09 Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i HRP20110436T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08
PCT/US2007/070572 WO2008103185A2 (fr) 2006-06-08 2007-06-07 Carboxamides substitués

Publications (1)

Publication Number Publication Date
HRP20110436T1 true HRP20110436T1 (hr) 2011-08-31

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110436T HRP20110436T1 (hr) 2006-06-08 2011-06-09 Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i

Country Status (31)

Country Link
US (1) US7960419B2 (fr)
EP (1) EP2076502B1 (fr)
JP (1) JP5108878B2 (fr)
KR (1) KR101051559B1 (fr)
CN (1) CN101466691B (fr)
AT (1) ATE509921T1 (fr)
AU (1) AU2007347428B2 (fr)
BR (1) BRPI0712862A2 (fr)
CA (1) CA2652074C (fr)
CR (1) CR10410A (fr)
CY (1) CY1111588T1 (fr)
DK (1) DK2076502T3 (fr)
EA (1) EA014233B1 (fr)
EC (1) ECSP088939A (fr)
ES (1) ES2362949T3 (fr)
HK (1) HK1131984A1 (fr)
HR (1) HRP20110436T1 (fr)
IL (1) IL195632A (fr)
MA (1) MA30620B1 (fr)
MX (1) MX2008015485A (fr)
MY (1) MY148084A (fr)
NO (1) NO341474B1 (fr)
NZ (1) NZ573352A (fr)
PL (1) PL2076502T3 (fr)
PT (1) PT2076502E (fr)
RS (1) RS51818B (fr)
SI (1) SI2076502T1 (fr)
TN (1) TNSN08506A1 (fr)
UA (1) UA95480C2 (fr)
WO (1) WO2008103185A2 (fr)
ZA (1) ZA200809111B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
PL2276759T3 (pl) 2008-04-04 2012-03-30 Lilly Co Eli 3-indazolilo-4-pirydyloizotiazole
WO2010146338A1 (fr) * 2009-06-15 2010-12-23 The University Of Edinburgh Composés amido-isothiazole et leur utilisation comme inhibiteurs de la 11 β-hsd1 dans le traitement du syndrome métabolique et des troubles apparentés
ES2540547T3 (es) 2009-09-16 2015-07-10 The University Of Edinburgh Compuestos de (4-fenil-piperidin-1-il)-[5-(1H-pirazol-4-il)-tiofen-3-il]-metanona y su uso
DK2563780T3 (en) 2010-04-29 2015-07-27 Univ Edinburgh 3,3-DISUBSTITUEREDE- (8-aza-bicyclo [3.2.1] oct-8-yl) - [5- (1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONER as inhibitors of 11 ( BETA) -HSD1
NO2921489T3 (fr) 2012-11-13 2018-02-03
JP2019529452A (ja) 2016-09-23 2019-10-17 バイエル・アクチエンゲゼルシヤフト N3−環状置換チエノウラシルおよびその使用
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
EP1435948A1 (fr) * 2001-08-06 2004-07-14 Pharmacia Italia S.p.A. D riv s d'aminoisoxazole agissant comme inhibiteurs de la kinase
EP1667983A4 (fr) * 2003-09-23 2010-07-21 Merck Sharp & Dohme Modulateurs pyrazole de recepteurs de glutamate metabotropiques
CN1984899B (zh) * 2004-05-12 2011-07-27 先灵公司 Cxcr1和cxcr2趋化因子拮抗剂
BRPI0515571A (pt) * 2004-09-23 2008-07-29 Pfizer Prod Inc agonistas de receptor de trombopoetina

Also Published As

Publication number Publication date
JP2009539874A (ja) 2009-11-19
UA95480C2 (uk) 2011-08-10
ATE509921T1 (de) 2011-06-15
ECSP088939A (es) 2009-01-30
ES2362949T3 (es) 2011-07-15
PT2076502E (pt) 2011-06-07
CA2652074C (fr) 2013-08-06
CR10410A (es) 2008-11-28
MX2008015485A (es) 2009-03-06
HK1131984A1 (en) 2010-02-12
WO2008103185A2 (fr) 2008-08-28
NZ573352A (en) 2011-10-28
NO20085028L (no) 2008-12-02
EP2076502B1 (fr) 2011-05-18
NO341474B1 (no) 2017-11-27
US20090182025A1 (en) 2009-07-16
RS51818B (en) 2011-12-31
PL2076502T3 (pl) 2011-09-30
IL195632A0 (en) 2009-09-01
AU2007347428B2 (en) 2012-02-09
DK2076502T3 (da) 2011-07-25
CN101466691A (zh) 2009-06-24
EA200870516A1 (ru) 2009-06-30
MY148084A (en) 2013-02-28
CA2652074A1 (fr) 2008-08-28
IL195632A (en) 2013-11-28
WO2008103185A3 (fr) 2008-10-30
TNSN08506A1 (en) 2010-04-14
EA014233B1 (ru) 2010-10-29
CN101466691B (zh) 2011-07-27
MA30620B1 (fr) 2009-08-03
CY1111588T1 (el) 2015-10-07
SI2076502T1 (sl) 2011-09-30
AU2007347428A1 (en) 2008-08-28
BRPI0712862A2 (pt) 2012-12-18
KR20090008460A (ko) 2009-01-21
US7960419B2 (en) 2011-06-14
KR101051559B1 (ko) 2011-07-22
EP2076502A2 (fr) 2009-07-08
ZA200809111B (en) 2009-12-30
JP5108878B2 (ja) 2012-12-26

Similar Documents

Publication Publication Date Title
HRP20110436T1 (hr) Supstituirani karboksamidi kao antagonisti metabotropnih receptora iz skupine i
HRP20210459T1 (hr) Supstituirani derivati oksopiridina
RS51137B (sr) Derivat benzimidazola i njegova upotreba kao antagonista receptora aii
HRP20180528T1 (hr) Derivati naftiridina, korisni kao antagonisti alfa-v-beta-6 integrina
CA2334298A1 (fr) Antagonistes des recepteurs y5 neuropeptidiques
HRP20050253B1 (hr) Diaril eteri kao opioid antagonisti opioidnih receptora
ATE445609T1 (de) Substituierte thiophenderivate als glucagonrezeptorantagonisten, herstellung und therapeutische anwendungen
HRP20120830T1 (hr) Imidazolkarboksamidi
DK1735278T3 (da) Histamin H3-receptormidler, fremstilling og terapeutiske anvendelser
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
JP2016506387A5 (fr)
HRP20171515T1 (hr) Spojevi fenoksietilpiperidina
HRP20120505T1 (hr) Supstituirani n fenilmetil oksoprolin amidi kao antagonisti receptora p x i postupci njihove upotrebe
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
DE602004021959D1 (de) Verbindungen mit agonistischer wirkung am beta2-adrenergen rezeptor und am muscarinischen rezeptor
HRP20220263T1 (hr) Fenil-2-hidroksi-acetilamino-2-metil-fenil spojevi
JP2009539874A5 (fr)
MX2012001160A (es) Agonistas del receptor de esfingosina-1-fosfato.
RU2010129967A (ru) Изотиазолидин-1, 1-диоксидные производные и тетрагидро2н-1, 2-тиазин-1, 1-диоксидные производные как модуляторы р2х7
PE20091431A1 (es) Compuestos derivados de azetidinas, su preparacion y su aplicacion en terapeutica
RU2003104794A (ru) Производные 4-фенилпиридина в качестве антагонистов рецептора нейрокинина 1
MXPA04003056A (es) Derivados de 4?piperidin-4-iliden-(3-carbamoilfenil)metil? benzamida y su uso para tratamiento de dolor, lesiones espinales o transtornos gastrointestinales.
ATE399164T1 (de) Antagonisten des opioidrezeptors